UNITAID approach to working in markets to improve public health
Preview:
DESCRIPTION
Presentation with the occasion of the Technical Briefing at World Halth Assembly, Geneva, 18 May 2011
Citation preview
- 1. UNITAID approach to working in markets to improve public
health Technical Briefing World Health Assembly, Geneva 18 May,
2011 Brenda Waning
- 2. Session Agenda
- Brief overview of UNITAID: why and how UNITAID works through
markets to improve public health
- Key highlights of UNITAIDs portfolio to date: proof of concept
that market approaches work
- New opportunities for market interventions to improve
health
- Trends in organizations moving to adopt market approaches:
presentations from other stakeholders
- 3. UNITAID: a WHO Partnership moving markets Partners Working
towards the common goal of expanding access to health
- Est. 2006: Innovative finance mechanism based largely on air
tax levies from north & south
- secretariat: no in-country offices work with partners
- First and only UN organization to work exclusively through
markets to improve public health
- 4. UNITAID Goal Healthy markets, healthy people UNITAID aims to
promote healthy, dynamic market conditions whereby manufacturers
have incentives to invest and innovate , while at the same time
supply quality public health products at affordable prices and in
acceptable formulations that enable the maximum number of people to
access them.
- 5. What is a market?
- 6. Market impact framework UNITAID Intervention example: 2 nd
line ARV market
- 7. How UNITAID intervenes
-
- UNITAIDs role depends upon the particular circumstances in a
given market:
- Market catalyst: identifying and facilitating adoption and
uptake of new and/or superior public health products;
- Market creator: providing incentives for manufacturers to
produce otherwise unattractive products with low demand that yield
little profit but substantial public health benefit to those in
need; and
- Market fixer: addressing severe market inefficiencies (e.g.
grossly inaccurate demand forecasts and excessive transaction
costs) that contribute to low access to quality-assured public
health products.
- 8. UNITAID examples (a few)
- Second-line ARV (& tenofovir) programs
- Expand TB (diagnostic line probe assay)
- Paediatric programs for HIV/AIDS & TB
- Affordable Medicines Facility for Malaria (AMFm)
-
-
- WHO Prequalification of Medicines Programme
-
-
- Strategic rotating stockpile for TB medicines
-
-
- Market intelligence systems
- 9. Market intelligence: the GPS of market interventions Used to
locate "global positions" around interventions before & after
implementation UNITAID accounts for > 90% market for paediatric
ARVs in fixed-dose combination form, 2009* 90% pediatric &
adult 1 st line ARVs made by Indian generic producers, 2008 *
- 10. New opportunities: the Decade of Diagnostics
- Unprecedented innovation in diagnostics technology
-
- Better chemistry, simpler to use, more affordable
-
- Finally will be able to bring diagnostics to people and regions
previously underserved
-
- Dramatic breakthrough in lab-based tuberculosis diagnostic
technology
- Malaria Rapid Diagnostic Tests
-
- From labs (microscopes) to homes (disposable Point of Care
tests)
-
- From central labs to clinics (Point of Care tests)
- 11. CD4 Product Pipeline*
- 12. Viral Load & EID Product Pipeline*
- 13. UNITAID is one of several players working to keep markets
in balance to improve public health
-
- UNITAID showed proof of concept: market interventions have
substantial, long term impact far beyond country recipients
-
- Many others now adopting market approaches: coordination &
collaboration to leverage relative strengths & maximize use of
resources towards achieving collective public health goals
- 14.
- Coordinator, Market Dynamics